// App-Quantinova.ai

Tu1778 : Faecalibacterium prausnitzii Prevents Irritable Bowel Syndrome-Like Symptoms in Both Murine Low Grade Chronic Inflammation and Acute Stress Models

Researchers

Presenter

  • Sylvie Miquel

Principal Investigators

  • Florian Chain

  • Philippe Langella

  • Luis G. Bermudez-Humaran

  • Jane M. Natividad

  • Marion Gillet

  • Jennifer Jury

  • Jun Lu

  • Harry Sokol

  • Vassilia Theodorou

  • Premysl Bercik

  • Elena F. Verdu

Medical Centers

  • Farncombe Institute, McMaster University, Hamilton, Ontario, Canada

  • UMR 1331 ToxAlim, INRA, Toulouse, France

  • Institut MICALIS, INRA, Jouy en Josas, France

Locations

  • France

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory bowel disease

  • Irritable Bowel Syndrome

  • Dysbiosis

  • Ulcerative colitis

Biomarkers

  • Interleukin 4

  • Interleukin 6

  • Interleukin-22

  • Interferon

Drug/Treatment

  • IL-4

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved